Clinical Trial Update: A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Simulators [Phase 3]

View source ↗

Summary

Phase 3 trial of SPD465 in young adults with ADHD using driving simulators has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• SPD465

Snippet

Sponsor: Shire | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: WITHDRAWN